Relationship between the oval cells and development of hepatocellular carcinoma in rats

World Chinese Journal of Digestology

Volumn 10, Issue 10, 2002, Pages 1133-1139

  Gong, Jia Qing ^a   Fang, Chi Hua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; CYCLINE; MESSENGER RNA; MYC PROTEIN; STEM CELL FACTOR; ULINASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SHAPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER OVAL CELL; NONHUMAN; PATHOLOGY; RAT;

EID: 0036774293     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Dominguez-Malagon H, Gaytan-Graham S. Hepatocellular carcinoma: An update. Ultrastruct Pathol 2001;25:497-516
2. Hou L, Li Y, Jia YH, Wang B, Xin Y, Ling MY, Lu S. Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells inmice. World J Gastroenterol 2001;7:532-536
3. Tang ZY, Sun FX, Tian J, Ye SL, Liu YK, Liu KD, Xue Q, Chen J, Xia JL, Qin LX, Sun SL, Wang L, Zhou J, Li Y, Ma ZC, Zhou XD, Wu ZQ, Lin ZY, Yang BH. Metastatic human hepatocellular carcinoma models in nude mice and cell line withmetastatic potential.World J Gastroenterol 2001;7:597-601
4. Tang ZY. Hepatocellular carcinoma - cause, treatment and metastasis.World J Gastroenterol 2001;7:445-454
5. Qin LX, Tang ZY. The prognostic significance of clinical and pathologica 1 features in hepatocellular carcinoma. World J Gastroenterol 2002;8:193-199
6. Zhang G, Long M, Wu ZZ, Yu WQ.Mechanical properties of hepatocellular carcinoma cells. World J Gastroenterol 2002;8:243-246
7. Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen ZC, Zhang SJ. Characterization of focal hepatic lesions with SPIO-enhanced MRI. World J Gastroenterol 2002;8:82-86
8. Fu JM, Yu XF, Shao YF. Telomerase and primary liver cancer. Shijie Huaren Xiaohua Zazhi 2000;8:461-463
9. Su YH, Zhu SN, Lu SL, Gu YH.HCV genotypes expression in hepatocellular carcinoma by reverse transcription in situ polymerase chain reaction. Shijie Huaren Xiaohua Zazhi 2000,8:874-878
10. Housset C. Biliary epithelium, hepatocytes and oval cells. Rev Prat 2000;50:2106-2111
11. Hixson DC, Brown J, McBride AC, Affigne S. Differentiation status of rat ductal cells and ethionine-induced hepaticcarcinomas defined with surface-reactive monoclonal antibodies. Exp Mol Pathol 2000;68:152-169
12. Mao H, Zhao MF, Feng JJ. The change of I1-2 malonydialdehyde in rats induced liver carcinoma by DAB.Chin J Gastroenrol Hepatol 1999;8:175-176
13. Zhang JZ. Carcinohistogenesis and expression of alpha fetoprotein in experimental hepatocarcinoma. J Clin Exp Pathol 1999;15: 224-226
14. Okuhama Y, Shiraishi M, Higa T, Tomori H, Taira K, Mamadi T, Muto Y.Protective effects of ulinastatin against ischemia-reperfusion injury. J Surg Res 1999;82:34-42
15. Koizumi R, Kanai H, Maezawa A, Kanda T, Nojima Y, Naruse T. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron 2000;84:347-353
16. Badve S, logdberg L, Sokhi R, SigaL SH, Botros N, Chae S, Das KM, Gupta S. An antigen reacting with das-1 monoclonal antibody is ontogenically regulated in diverse organs including liver and indicates sharing of developmental mechanisms among cell lineages. Pathobiology 2000;68:76-86
17. Benedetti A, Di-Sario A, Casini A.Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: An in vitro and in vivo study. Gastroenterology 2001; 120:545-556
18. Toda K, Kumagai N, Tsuchimoto K, Inagaki H, Suzuki T, Oishi T, Atsukawa K, Saito H, Morizane T, Hibi T, Ishii H.Induction of hepatic stellate cell proliferation by IPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis. J Gastroenterol 2000;35:214-220
19. Mc Crudden R, Iredale JP. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histol Histopathol 2000;15:1159-1168
20. Satoh T, Ichida T, Matsuda Y, Sugiyama M, Yonekura K, Ishikawa T, Asakura H. Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis. J Gastroenterol Hepatol 2000;15:402-411
21. Shan CM, Li J. Study of apoptosis in human liver cancers. World J Gastroenterol 2002;8:247-252
22. Paku S, Schnur J, Nagy P, Thorgeirsson SS. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol 2001;158:1313-1323
23. Toshihior M. Hepatic stem cells: Form brone marrow cells to hepaticytes. Biochem Biophy Res Commun 2001;281:1-5
24. Vessey CJ, dela Hall PM. Hepatic stem cells: A review. Pathology 2001;33:130-141
25. Xiao JC, Ruck P, Kaiserling, E.Small epithelial cells in extrahepatic biliary atresia: Electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells.Histopathology 1999;35:454-460
26. Theise ND, Saxena R, Portmann BC, Thung SN, Yee H, Chiriboga L, Kumar A, Crawford JM. The canals of Hering and hepatic stem cells in humans. Hepatology 1999;30:1425-1433
27. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, Novelli M,Prentice G, Williamson J, Wright NA. Hepatocytes from non-hepatic adult stem cells. Nature 2000;406:257-262
28. Hsu HC, Ema H, Osawa M, Nakamura Y, Suda T, Nakauchi H. Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver. Blood 2000; 96: 3757-3762
29. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999;29:1193-1198
30. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Borne marrow as a potential source of hepatic oval cells. Science 1999;284:1168-1170
31. Ma X, Qiu DK, Peng YS. Immunohistochemical study of hepatic oval cells in human chronic viralhepatitis. World J Gastroenterol 2001;7:238-242
32. Arroyo MP, Wang TS. Schizosaccharomyces pombe replication and repair proteins: Proliferating cell nuclear antigen(PCNA). Methods 1999;18:335-328
33. Miura M. Detection of chromation-bound PCNA in mammalian cells and its use to study DNA excision require. J Radiat Res 1999;40:1-12
34. WAFI/CIPI and PCNA in human hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2002;10:145-148
35. Jonas JC, Iaybutt DR, Steil GM, Trivedi N, Pertusa JG, Van de Casteele M, Weir GC, Henquin JC.High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells. J Biol Chem 2001;276:35375-35381
36. Deng CX, Brodie SG. Roles of BRCA1 and its interacting proteins. Bioessays 2000;22:728-737
37. Fields WR, Desiderio JG, Putnam KP, Bombick DW, Doolittle DJ. Quantification of changes in C-myc mRNA levels in normal human bronchial epithelial (NHBE) and lung adenocarcinoma (A549) cells following chemical treatment. Toxicol Sci 2001;63: 107-114
38. Wang LD, Zhou Q, Wei JP, Yang WC, Zhao X, Wang LX, Zou JX, Gao SS, Li YX, Yang C. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 andC-myc in esophageal carcinogenesis studied with a high-risk population in northern China.World J Gastroenterol 1998;4:287-293
39. Langa F, Iafon I, Vandormael-Pournin S, Vidaud M, Babinet C, Morello D. Healthy mice with an altered C-myc gene: role of the 3″ untranslated region revisited. Oncogene 2001;20:4344-4353
40. Kobayashi H.Suppression of urokinase expression and tumor metastasis by bikuninoverexpression. Hum Cell 2001;14:233-236
41. Kobayashi H, Suzuki M, Tanaka Y, Hirashima Y, Terao T. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways. J Biol Chem 2001;276:2015-2022
42. Kobayashi H, Suzuki M, Sun GW, Hirashima Y, Terao T. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor. Biochim Biophys Acta 2000;1481:310-316